Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Golareh, Habibi"'
Autor:
Sandra E. Dunn, Michael Pollak, Marco Gottardis, Joan Carboni, Robert I. Nicholson, Helen E. Jones, Pauline Finlay, Julia M.W. Gee, Eugene Park, Anna L. Stratford, Michelle Y.C. Wang, Hamid Masoudi, Kaiji Hu, Golareh Habibi, Jennifer H. Law
Supplementary Figure 1 from Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ed96153bfbcc226a63b1ca283392dc9
https://doi.org/10.1158/0008-5472.22375809.v1
https://doi.org/10.1158/0008-5472.22375809.v1
Publikováno v:
Molecular and Biochemical Parasitology. 153:125-132
Protozoan parasites of the genus Leishmania have a digenetic lifecycle, alternating between the promastigote and amastigote stages. The extracellular promastigote resides within a sandfly vector, while the obligate intracellular amastigote stage repl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45d02926a62e50ba8a13ae38c9ec5800
https://doi.org/10.1016/j.molbiopara.2007.02.010
https://doi.org/10.1016/j.molbiopara.2007.02.010
Autor:
Nancy Dos, Santos, Golareh, Habibi, Michelle, Wang, Jennifer H, Law, Heather N, Andrews, Daniel, Wei, Timothy, Triche, Shoukat, Dedhar, Sandra E, Dunn
Publikováno v:
Translational Oncogenomics
Urokinase-type plasminogen activator (uPA) is associated with cancer recurrence where the most evidence comes from studies in breast cancer. According to the European Organization for Research and Treatment of Cancer, uPA is considered one of the mos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::737597bce4f74e5acfb4599dbe9c4a61
https://pubmed.ncbi.nlm.nih.gov/23645983
https://pubmed.ncbi.nlm.nih.gov/23645983
Autor:
Robert Ian Nicholson, Joan M. Carboni, Eugene Park, Jennifer Law, Sandra E. Dunn, Julia Margaret Wendy Gee, Kaiji Hu, Anna L. Stratford, Michael Pollak, Michelle. Y. C. Wang, Hamid Masoudi, Pauline Finlay, Helen E. Jones, Marco M. Gottardis, Golareh Habibi
Publikováno v:
Cancer research. 68(24)
Drugs that target the insulin-like growth factor-I receptor (IGF-IR) and/or insulin receptor (IR) are currently under investigation for a variety of malignancies including breast cancer. Although we have previously reported that IGF-IR expression in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44fead3a1786b8aabb06500f37ef73b0
https://pubmed.ncbi.nlm.nih.gov/19074892
https://pubmed.ncbi.nlm.nih.gov/19074892
Autor:
Jennifer Law, Sandra E. Dunn, Hamid Masoudi, Samuel Leung, Karen A. Gelmon, Torsten O. Nielsen, David G. Huntsman, Michael Pollak, Golareh Habibi, Dmitry Turbin
Publikováno v:
Breast Cancer Research : BCR
Introduction: Gene expression analysis is used to subtype breast cancers such that the most aggressive tumors are identified, but translating this into clinical practice can be cumbersome. Our goal is to develop a universal biomarker that distinguish
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac4358bd1958d15aef70f267f33d8161
https://doi.org/10.1186/bcr2156
https://doi.org/10.1186/bcr2156
Autor:
Samuel Aparicio, Eugene Park, Uwe Klinge, Wan L. Lam, Marco A. Marra, Anna L. Stratford, Arezoo Astanehe, Kaiji Hu, Sandra E. Dunn, Peter R. Mertens, Timon P H Buys, Torsten O. Nielsen, Helen Jiang, Trevor J. Pugh, Ashleen Shadeo, Golareh Habibi
Publikováno v:
Breast cancer research 9(5), R61 (2007). doi:10.1186/bcr1767
Breast cancer research : BCR
Breast cancer research : BCR
Introduction Basal-like breast cancers (BLBCs) are very aggressive, and present serious clinical challenges as there are currently no targeted therapies available. We determined the regulatory role of Y-box binding protein-1 (YB-1) on epidermal growt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f909be2505f3adfeed1cf8239966f97